These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2425456)

  • 1. Functional analysis of the HLA-A2/Aw68 recombinant molecule HLA-Aw69: Epstein-Barr virus specific cytotoxic T cells restricted through Aw69 can utilise restricting determinants on Aw68 but not on A2.
    Wallace LE; Kennedy LJ; Landon C; Bodmer JG; Rickinson AB
    Tissue Antigens; 1986 May; 27(5):298-307. PubMed ID: 2425456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule.
    Salter RD; Clayberger C; Lomen CE; Krensky AM; Parham P
    J Exp Med; 1987 Jul; 166(1):283-8. PubMed ID: 2439636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody recognizing a determinant shared by HLA-A2 and HLA-Aw69 (A28* variant).
    Antonelli P; Choo SY; Nisperos B; Hansen JA
    Tissue Antigens; 1985 Aug; 26(2):114-20. PubMed ID: 2414860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants recognized by human cytotoxic T cells on a natural hybrid class I HLA molecule.
    Clayberger C; Holmes N; Wang PL; Koller TD; Parham P; Krensky AM
    J Exp Med; 1985 Nov; 162(5):1709-14. PubMed ID: 2414389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon shuffling in vivo can generate novel HLA class I molecules.
    Holmes N; Parham P
    EMBO J; 1985 Nov; 4(11):2849-54. PubMed ID: 3877632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1.
    Cerundolo V; Tse AG; Salter RD; Parham P; Townsend A
    Proc Biol Sci; 1991 May; 244(1310):169-77. PubMed ID: 1715994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allospecific T cell recognition of HLA-A2 antigens: evidence for group-specific and subgroup-specific epitopes.
    Wallace LE; Houghton MA; Rickinson AB; Epstein MA; Bradley BA
    Immunogenetics; 1985; 21(3):201-14. PubMed ID: 2580783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C molecules.
    Chen BP; Lam V; Kraus EE; DeMars R; Sondel PM
    Hum Immunol; 1989 Oct; 26(2):137-47. PubMed ID: 2479624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation of an HLA-A2/HLA-Aw69 alloantigenic determinant on an HLA-A3 molecule by site-directed mutagenesis.
    Layet C; Kahn-Perles B; Pontarotti P; Ferrier P; Sire J; Lemonnier FA
    J Immunol; 1987 Apr; 138(7):2197-201. PubMed ID: 2435791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
    Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
    J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human hybridoma producing a pure anti-HLA-A2 monoclonal antibody.
    Wallace EF; Foung SK; Bradbury K; Pask SL; Grumet FC
    Hum Immunol; 1990 May; 28(1):65-9. PubMed ID: 2160447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells.
    Gaston JS; Wallace LE; Rickinson AB; Epstein MA; Pious D
    Immunogenetics; 1984; 19(6):475-86. PubMed ID: 6329950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity.
    Gotch FM; Kelly C; Ellis SA; Wallace L; Rickinson AB; van der Poel J; Crumpton MJ; McMichael AJ
    Immunogenetics; 1985; 21(1):11-23. PubMed ID: 2981768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.
    Storkus WJ; Salter RD; Alexander J; Ward FE; Ruiz RE; Cresswell P; Dawson JR
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):5989-92. PubMed ID: 2068075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I cross-restricted T cells reveal low responder allele due to processing of viral antigen.
    Bodmer HC; Gotch FM; McMichael AJ
    Nature; 1989 Feb; 337(6208):653-5. PubMed ID: 2537466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Dec; 158(6):1804-21. PubMed ID: 6196431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the functional epitopes on different HLA-A2 molecules.
    Goulmy E; van der Poel J; Giphart M; van Rood JJ
    Immunogenetics; 1984; 20(1):13-21. PubMed ID: 6204938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
    Khanna R; Burrows SR; Nicholls J; Poulsen LM
    Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.